The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
This year at the EHAP congress, Biolog-id presents its new solution for chemotherapies, developed in partnership with Institut Curie in Paris.
Biolog-id is rich of a portfolio of 62 international lodged patents.
RFID applications :
· labile blood products
· plasma for fractionation
· chemotherapy preparations
Website : www.biolog-id.com